OQS
INDV icon

Occudo Quantitative Strategies’s Indivior Pharmaceuticals INDV Stock Holding History

Occudo Quantitative Strategies’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$746K Sell
20,270
-20,103
-50% -$664K 0.04% 444
2025
Q4 		$1.45M Buy
40,373
+8,129
+25% +$248K 0.1% 252
2025
Q3 		$777K Buy
+32,244
New +$675K 0.09% 299

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Occudo Quantitative Strategies's INDV Position: Q1 2026 in Review

Occudo Quantitative Strategies reduced its Indivior Pharmaceuticals (INDV) stake by 50% in Q1 2026, selling an estimated $664K and leaving 20,270 shares worth $746K. The position accounts for 0.04% of the portfolio, ranked #444.

Occudo Quantitative Strategies first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.45M in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Occudo Quantitative Strategies held 20,270 shares of Indivior Pharmaceuticals worth $746K as of Q1 2026.
  • Occudo Quantitative Strategies sold 20,103 Indivior Pharmaceuticals shares in Q1 2026, an estimated $664K.
  • Indivior Pharmaceuticals made up 0.04% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #444 holding.
  • Occudo Quantitative Strategies first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Occudo Quantitative Strategies's Indivior Pharmaceuticals position peaked at $1.45M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.